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Abstract
Background: Recruiting and consenting women to peripartum trials can be challenging as the women concerned
may be anxious, in pain, and exhausted; there may also be limited time for discussion and decision-making to occur. To
address these potential difficulties, we undertook a qualitative evaluation of the internal pilot of a trial (Got-it) involving
women who had a retained placenta (RP). We explored the experiences and views of women and staff about the
information and consent pathway used within the pilot, in order to provide recommendations for use in future
peripartum trials involving recruitment in emergency situations.
Methods: In-depth interviews were undertaken with staff (n = 27) and participating women (n = 22). Interviews were
analysed thematically. The accounts of women and staff were compared to identify differences and similarities in their
views about recruitment and consent procedures.
Results: Women and staff regarded recruitment as having been straightforward and facilitated by the use of simplified
(verbal and written) summaries of trial information. Both parties, however, conveyed discordant views about whether
fully informed consent had been obtained. These differences in perspectives appeared to arise from the different
factors and considerations impinging on women and staff at the time of recruitment. While staff placed emphasis on
promoting understanding in the emergency situation of RP by imparting information in clear and succinct ways, women
highlighted the experiential realities of their pre- and post-birthing situations, and how these had led to quick decisions
being made without full engagement with the potential risks of trial participation. To facilitate informed consent, women
suggested that trial information should be given during the antenatal period, and, in doing so, articulated a rights-based
discourse. Staff, however, voiced opposition to this approach by emphasising a duty of care to all pregnant women, and
raising concerns about causing undue distress to the majority of individuals who would not subsequently develop a RP.
Conclusions: By drawing upon the perspectives of women and staff involved in the same trial we have shown that they
may operate within different experiential and ethical paradigms. In doing so, we argue for the potential benefits of
drawing upon multiple perspectives when developing information and consent pathways used in future (peripartum)
trials.
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Background
Multicentre randomised trials frequently encounter diffi-
culties meeting their recruitment targets, resulting in ex-
tensions to recruitment periods and delays to reporting
and implementing findings [1, 2]. This has led to the devel-
opment of a substantial body of research that has explored
the challenges of recruitment and has demonstrated that
recruitment processes can be influenced by a complex mix
of factors. For instance, it has been shown that the way in
which trial information is presented to potential partici-
pants, including the language and terminology used, can
shape their understandings of a trial [3], and can impact on
‘opt-in’ levels [4, 5]. Such research has led to the develop-
ment of tools to promote effective recruitment processes
[6]. Understanding of ways in which the clinical setting of
a trial can impact on experiences of decision-making has
also increased, with studies highlighting the range of
contexts and circumstances in which individuals are asked
to consider participation, from emergency settings [7–9],
where decision-making may be deferred [10, 11], to
those where there is plenty of time for reflection and
discussion [12].
Research suggests that recruitment and informed con-
sent processes can also be influenced by staff perceptions
and experiences. For example, staff can find recruitment
difficult when there are too many competing demands on
their time [13], and may be reluctant to approach those
they perceive as vulnerable [14, 15]. In addition, staff may
decide not to approach some eligible people due to their
own lack of equipoise with regards to particular groups or
individuals [16], or concerns about compromising an on-
going therapeutic relationship [17]. These kinds of issues,
considerations and concerns often prove to be more
complex and challenging than anticipated at a trial’s
outset. Thus, as trials move into new clinical areas and
address novel questions, new and unforeseen issues are
likely to arise.
It has also been shown that information and consent
pathways used in recruitment processes may not neces-
sarily lead to a clear and lasting understanding of a trial’s
purpose, design and implications [18, 19]. This has
raised concerns about whether fully informed consent
can be gained, especially in trials involving recruitment
of potentially vulnerable individuals or those who are
eager to access resources or treatments, which they
cannot afford or cannot access through routine clinical
care [20–23].
It has been suggested that recruiting and consenting
to peripartum trials can create particular challenges and
difficulties because such trials involve approaching
women who may be anxious and in pain, and could be
experiencing mental, emotional and physical exhaustion
[24]. Potential participants may be subject to the effects
of analgesics which may further compromise their ability
to understand trial information and, hence, to give fully
informed consent [25–27]. In some intrapartum and
peripartum trials there may also only be a very limited
time period in which discussion and decision-making
can take place due to the time-critical nature of the
diagnosis and management of the life-threatening condi-
tion being studied [24, 25, 28]. These kinds of problems
are similar to those identified in neonatal intensive care
trials where recruitment can also take place shortly after
birth. In this setting, women and their partners have
been shown to vary in their reactions to research partici-
pation, with some being very clear about their course of
action and others describing their struggles with the
information they were given and the choices they were
required to make [29].
In recognition of the above and other potential diffi-
culties surrounding recruitment and consenting into
perinatal trials, we undertook a qualitative evaluation of
the internal pilot of the Got-it trial: a double-blind
randomised trial involving women who have a retained
placenta. Our key aim was to explore the experiences
and views of women and trial staff about the information
and consent pathway used within the pilot with close
attention paid to the potentially challenging context
within which recruitment took place. Our objectives
were to provide recommendations that might be used to
refine the information and consent processes used in the
main Got-it trial; and, to offer insights which could be
used to inform the information and consent pathways
used in future peripartum trials.
Methods
The research setting
The Got-it trial is a randomised, placebo-controlled,
double-blind, pragmatic UK-wide randomised controlled
trial (RCT) involving women who have a retained
placenta (RP) recruited from delivery wards in UK
maternity hospitals. RP is a major cause of postpartum
haemorrhage and affects around 2 % of vaginal deliveries
in the UK. It is diagnosed when the placenta is not
delivered within 30 minutes following active manage-
ment or 60 minutes after physiological management
followed by active management of the third stage of
labour after delivery of the baby [30]. The current defini-
tive management of RP is manual removal of the
placenta, which is a surgical procedure requiring trained
personnel and an operating theatre [30]. The aim of the
Got-it trial is to determine whether use of glyceryl
trinitrate (GTN) spray, as compared to a placebo, can
facilitate delivery of the placenta without having to
undertake manual or surgical delivery in theatre. GTN is
a drug which was originally developed for the prevention
and relief of angina attacks. Its side-effects include head-
ache, dizziness, flushing/feeling hot, a drop in blood
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pressure or a rise in pulse rate. In the clinical context of
RP, it could also affect blood loss due to its primary
mode of action as a muscle relaxant.
The trial’s inclusion and exclusion criteria are listed in
Table 1. During the pilot, once a diagnosis of RP had
been made, potential recruits were approached by a del-
egated and trained member of the clinical or research
team. These women were given written information in
the form of a one-page summary leaflet accompanied by
a detailed participant information sheet. The trial team
developed the summary information because it was felt
that, due the emotional and/or physical impact of birth,
women might find the full information sheet too lengthy
and burdensome to read. RP is also a potentially life-
threatening complication with the amount of blood loss
increasing the longer a placenta is retained. Provision of
summary information was, therefore, also considered
appropriate to facilitate timely consent and definitive
management of the RP if it was not delivered following
administration of the trial drug. Women were also given
a verbal explanation of the trial that covered all the
elements in the participant information sheet and
consent form. Women who gave their consent were
randomised to receive GTN or a placebo spray, which
they self-administered under their tongue (two puffs).
The placebo spray was designed to be identical in taste
and appearance to GTN so neither participants nor staff
could determine the outcome of randomisation. Women
whose placentas were not delivered within 15 minutes
were taken to theatre for manual removal of the
placenta under regional or general anaesthesia, with the
method of anaesthetic being determined by the clinical
team and being dependent on the urgency of need for
placental delivery.
The trial, as already indicated, comprises two phases:
an internal pilot followed by a substantive RCT. The
pilot commenced in October 2014 and involved eight
sites that entered the pilot in a staggered way. Its pur-
pose was to provide evidence and reassurance of the
feasibility and effectiveness of all trial processes, includ-
ing those relating to recruitment and obtaining informed
consent. In order to progress to the substantive RCT,
the pilot had to reach a target of 75 recruits within
the first 7 months of recruitment. This target was
exceeded with 87 women having been recruited by
the end of April 2015; very low decliner rates were
also reported across the pilot sites, with only six of
those approached choosing not to take part. The sub-
stantive trial is now underway and is due to be com-
pleted in 2017.
Qualitative study design
In order to gain multiple perspectives on the informa-
tion and consent pathway used in the trial’s pilot phase,
both trial-recruited women, women who declined
participation, and recruiting staff were invited to take
part in the qualitative study. Data were collected by
means of in-depth interviews because these afforded the
flexibility needed for participants (staff and women) to
raise and discuss issues which they perceived as salient,
including those unforeseen at the study’s outset [31, 32].
The use of one-to-one interviews also afforded privacy,
allowing participants to share personal experiences
and negative views about the trial’s recruitment and
consent procedures, should they chose to do so. The
study employed an iterative approach that entailed
simultaneous data collection and analysis [33]. This
allowed the areas explored in the interviews to be re-
vised in light of emerging findings. Interviews with
women and staff were undertaken in parallel, enabling
issues raised by one participant group (e.g. women) to
be explored in interviews undertaken with the other
group (e.g. staff ).
Sample and recruitment
Recruitment was undertaken in all eight centres involved
in the pilot study and took place throughout the pilot’s
duration (i.e. from November 2014 to April 2015) to
accommodate the staggered entry of sites into the pilot
and allow for the inclusion of participants from all sites.
Table 1 Trial inclusion and exclusion criteria
Inclusion criteria
Women with a retained placenta
Women aged 16 or over
Women having a vaginal delivery (including women with a previous
caesarean section)
Haemodynamic stability (systolic blood pressure more than
100 mmHg and pulse less than 110 beats per min)
Over 14 weeks’ gestation
Exclusion criteria
Unable to give informed consent
Suspected placenta accreta/increta/percreta
Multiple pregnancy
Women undergoing an instrumental vaginal delivery in theatre
Allergy or hypersensitivity to nitrates or any other constituent of the
formulation
Taken alcohol in the last 24 hours
Concomitant use of phosphodiesterase inhibitors (such as sildenafil,
tadalafil, or vardenafil)
Contra-indication due to one of the following: severe anaemia,
constrictive pericarditis, extreme bradycardia, incipient glaucoma,
glucose-6-phosphate dehydrogenase deficiency, cerebral haemorrhage
and brain trauma, aortic and/or mitral stenosis and angina caused by
hypertrophic obstructive cardiomyopathy, circulatory collapse,
cardiogenic shock and toxic pulmonary oedema
Currently participating in another CTIMP
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Women were approached within 2–3 days of having
taken part in the trial and were either given a recruit-
ment pack while in hospital, or if they had already
been discharged, a pack was posted out to them. Staff
were given or sent recruitment packs. In both cases,
an ‘opt-in’ procedure was used and recruitment mate-
rials made potential participants aware that the team
conducting the interviews were independent from the
clinical trial team.
Women were purposively sampled so there was diversity
in the final sample in terms of age, education/occupation,
parity and ethnicity (see Table 2). Staff were selected for
interviews if they had been involved in trial delivery,
recruitment or consenting of the women. Across the
centres, these staff comprised obstetricians, research
midwives and midwifery staff. All participants gave their
written informed consent to take part in an interview.
Data collection and analysis
Interviews were conducted by NH who has over 20 years
of experience of carrying out qualitative interviews on
sensitive topics. To reduce potential problems with
recall bias, women were interviewed within 4 weeks of
having taken part in the pilot trial. While women were
given the choice of a phone or face-to-face interview,
virtually all opted to be interviewed by phone; most staff
also opted for a phone interview. No obvious differences
were observed between the content and quality of inter-
views undertaken face-to-face and those done by phone.
Interviews were informed by topic guides developed in
the light of literature reviews, inputs from staff and lay
advisors, and focussed upon: women’s experiences of
birth; the views of women and staff about the trial and
trial procedures; the method, timing and content of in-
formation delivery; and, the information and consent
pathway used during the trial’s pilot phase (see Table 3).
As indicated above, the topic guides were also revised in
light of emerging findings. For example, in the initial
phase of interviewing, women and staff were all asked a
very general question about the timing of information-
giving in the pilot – What do you think about the timing
of the information given in the Got-it trial? After most
women spontaneously volunteered that they would have
appreciated receiving information about the trial during
their pregnancy, the staff topic guides were expanded to
explore their views about providing such information dur-
ing the antenatal period. Interviews with women averaged
around 25 minutes and those with staff 45 minutes. In all
but two cases (where women had to end the interview
abruptly to attend to their babies) all key areas in the topic
guides were covered and explored in depth. Data collec-
tion continued until data saturation was achieved; that is,
until no new findings or themes could be identified in
new data collected.
All interviews were digitally recorded and transcribed in
full. As already indicated, data analysis was iterative and
commenced as soon as data collection began. Data were
analysed thematically by JL and NH using the method of
constant comparison [34]. This thematic approach entailed
individual interviews being read through repeatedly before
Table 2 Participant characteristics – women
Number %
Age (years)
Mean: range 30.7 18–40
< 30 years 8 36
Ethnic group
White British 17 77
South-east Asian 2 9
Other 3 14
Highest education level
School 7 32
Further education 2 9
Degree 8 36
Higher degree 5 23
Previous birthing experiences
Primagravidae 9 41
Previous retained placenta 5 39
Table 3 Areas of questioning explored in the topic guides
Topic guide – Women
• Demographic information
• Experiences of labour, birth and postpartum period
• Experience of consent pathway used in the Got-it trial
• Timing of approach for participation in the Got-it trial
• Understanding of trial and information
• Factors influencing decision to participate in Got-it
• Information needs
• Experiences of trial participation
• Views on research participation in general
Topic guide – Staff
• Demographic information
• Former trial experience
• Perceptions of the Got-it trial (equipoise)
• Involvement in the Got-it trial
• Recruitment and consenting experiences in the Got-it trial
• Perceptions of the consent pathway used in the Got-it trial
• Timing of approach for participation in the Got-it trial
• Participants’ understanding of trial and information
• Quality of participants’ consent
• Impact of research on HCP-patient relationships
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being cross-compared to identify issues and experiences
cutting across different accounts. A comparative analysis of
women’s and staff accounts was also undertaken to identify
differences and similarities in their views about recruit-
ment, consent procedures, and the timing of information
delivery − and the reasons for these. JL and NH undertook
independent analyses before meeting to discuss and reach
agreement on key findings and themes and to develop a
coding frame. The qualitative analysis software package
NVivo9 (QSR International) was used to facilitate data
coding and retrieval. Coded datasets were subjected to
further, in-depth analysis to identify additional themes and
illustrative quotations.
Ethical approval for the trial and the qualitative re-
search was given by Newcastle and North Tyneside 2
Research Ethics Committee. To safeguard confidential-
ity, all participants were allocated pseudonyms which
are used below.
Implementation group
An implementation group was put together for this study
comprising members of the trial team, staff representatives
from each of the pilot trial sites, patient representatives,
the qualitative study team (JL, NH and CS) and a member
of the Trial Steering Committee. The findings reported
below were fed back to this group at the end of the pilot
phase of the trial. In light of these, the group compiled a
series of recommendations to facilitate the running of the
substantive trial, some of which focussed upon refining
the information/consent pathway. These are returned to
later in the paper.
Results
Forty-nine women and 37 staff were invited to participate.
Twenty-two (45 %) women and 27 (73 %) staff were
interviewed and full details about the sample can be found
in Tables 2 and 4. Although it had been our intention
to interview ‘decliners’, four of the six women who de-
clined trial participation during the pilot were deemed
by clinical staff to be inappropriate to approach, and
the remaining two did not opt-in to the qualitative
study.
In keeping with quantitative data from the pilot (which
showed good levels of recruitment and very low decliner
rates) both women and staff presented their recruitment
experiences as having been relatively straightforward and
uncontroversial. However, while the trial was considered
easy to recruit into, views about the consenting proce-
dures and, more specifically, the timing of the information
needed to promote fully informed consent were more
mixed, with notable differences between women and staff.
Below, we consider these findings in more detail. We
begin with women’s perspectives and experiences of the
information and consent pathway used in the pilot and
how they thought it might be improved, before
moving onto staff accounts. In doing so, we attempt
to understand how, and why, the differences in their
perspectives arose.
Women’s views about the trial
In general, women conveyed very positive views about the
trial despite, in most cases, having subsequently had to go
to theatre for manual removal of the placenta. Women
described the trial as being a valuable and well-intended
piece of research and which, as Helen suggested, will
‘hopefully mean that women in the future won’t need to go
to theatre’. They also pointed out that the trial had been
very straightforward in terms of what had been
required of them: ‘I was happy to do it, ‘cause I thought
“it’s only 15 minutes to wait, to see if it (the spray)
works”’ (Hazel), and had entailed only very minimally
invasive procedures: ‘…like putting a spray under my
tongue, that didn’t bother me at all’ (Kirsty). In addition,
most women suggested that they had welcomed the
opportunity to try an alternative intervention rather than
going straight to theatre:
‘I think it made me thankful that they’d offered me an
alternative rather than just whisking me off to theatre
and sort of knocking me out or anything like that. It
made me feel like they were giving me all of the
possible options for the scenario that I was in. So I
felt like they were looking out for (me), not only for
my health, but psychologically as well.’ (Trina)
Table 4 Participant characteristics – healthcare professionals
Number %
Staffa (n = 27)
Doctors 10 37
Consultants 3 11
Clinical midwives 6 22
Labour ward leads 2 7
Research midwives 11 41
Highest education level
Professional qualification/diploma 2 7
Degree 17 63
Higher degree 8 30
Years in post
< 2 years 6 22
2–5 years 16 59
> 5 years 5 19
No previous trial experience 7 26
aDoctors were interviewed from seven sites, clinical midwives from four and
research midwives from all eight sites. At least two staff members, a research
midwife plus one other, were interviewed in seven sites
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As we will now go onto consider, as well as the simple
nature of the intervention (a spray) raising no disincen-
tive to participate, women’s earlier experiences of labour
and delivery were important components underlying
their positive views about the trial. We will also show
how these earlier experiences informed women’s prefer-
ences for information delivery as well as leading to many
later questioning whether their consent had been fully
informed.
Women’s views about information delivery and giving
informed consent
In the interviews, women were invited to talk about the
events that had led up to their taking part in the trial.
While this line of questioning prompted a minority (n = 3)
to describe a relatively straightforward and pain-free birth,
many recounted birthing experiences which had been
painful and often protracted and, for which, in some cases,
analgesics had been required:
‘It was really horrible. The pain was unbearable, it
really was totally unbearable for me. I was feeling like
“I will die of this thing.”’ (Amal, prescribed
diamorphine)
‘I’d already been in labour for about 30 hours, I was in
a lot of pain so I’d asked for an epidural… But then
several hours later – and my waters had broken at
this point – the epidural had come out slightly at the
back so I ended up without pain relief for the pushing
part, which was really painful.’ (Faith)
As well as having been left physically and emotionally
exhausted by these kinds of births, some women, includ-
ing Tracy below, highlighted additional distress which
had resulted from a complicated delivery and ensuing
concerns about their baby’s health and safety:
‘I started off on the labour on Sunday, it was like a
really, really slow labour, contractions just were never,
ever going to deliver a baby. So they induced me on the
Tuesday and within like half an hour my contractions
were like every 6 and 10, which were just too quick, my
body couldn’t handle it, I don’t think I could handle it.
So they slowed my labour down. I had diamorphine
and whatever else I could have. When I went to the
labour ward I had to have the clip on baby’s head to
check her heart because obviously she was struggling
with the contractions speeding up again. I just thought
it was just horrendous. I was so worried about her
(baby) and so scared.’ (Tracy)
In some cases, quick births were also described as
having had adverse physical and emotional impacts, with
Kirsty, for instance, sharing her experiences of having
gone into shock after a rapid and intense labour:
‘I’d been very vocal during the birth and then
afterward I went really quite quiet. Because everyone
was like, “are you sure you’re ok, are you alright?” and
they kept on checking I was ok… I think because it
happened all in all it was a quick birth, I think I was
in a bit of shock about that.’ (Kirsty)
Women also described how their distress had intensi-
fied after discovering that they had a RP. Notably, worry
and panic reactions were shared by those, such as Trina,
who had no prior knowledge of this type of condition
and who had assumed that it must be very serious:
‘You know when somebody says that there’s
something wrong and you’re not expecting there to
be, and you don’t know a lot about it, there were
moments that it was quite scary.’ (Trina)
Women’s experiences of, and views about, the
information and consent pathway
Given their pre-birth experiences, most women de-
scribed how, by the time they were approached to take
part in the trial, they had been ‘tearful and emotional
and exhausted’ (Anna), ‘overwhelmed’ (Arlene) and ‘at
the end of my tether’ (Hannah). As a consequence,
women described how they had valued being given a
succinct information leaflet to read rather than a full par-
ticipant information sheet, because, as Faith explained, ‘at
that point I was cross-eyed and it was just about all I
could take in’ and, as Celia elaborated, ‘it was easy to
understand, because I was not, you know, probably not
my normal self… I wasn’t up to being bamboozled or
overwhelmed with information or anything’. Others
described how they had simply been too exhausted and
distracted to read even the succinct written materials; and,
hence, how it had been very helpful to have had staff
present to go through the literature with them and
provide verbal descriptions and summaries of the trial.
Thus, women were generally very positive about
the content and mode of delivery of trial information
which, as Kate described, was ‘as good as it could
have been, given everything which was going on at
the time’. However, most also noted that, by the time
they had been approached to take part, they had
simply been too exhausted, distracted and/or emo-
tionally overwhelmed to assimilate and retain all the
information provided:
‘I genuinely think they probably told me everything
about the trial, but my head was elsewhere, I was
utterly exhausted.’ (June)
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‘…they (possible side effects of taking GTN) were on
the form but if I’m being honest, I cannot remember
what any of them were. I remember that the nurse
read them out and went through it with me but I was
utterly done in.’ (Faith)
Some women, including Heather, also reflected on
how their concentration and ability to take trial informa-
tion on board had been further compromised by their
awareness that they were in an emergency situation with
a lot of activity taking place around them:
‘I think I had the baby and I think the midwife were
kind of fiddling with the cord and trying to get things
out and then they were chatting to me… they were
putting the, eh cannula in my hand and stuff as well.
So I can’t remember all of it… and I was quite
anxious already, thinking am I going gonna have to
get this epidural done?’ (Heather)
In addition, most described recognising, with hindsight,
that the approach to take part in the trial had taken place
at a time when they had been in a very vulnerable emo-
tional situation; one which had resulted in their
consenting from ‘a point of desperation’ as Arlene aptly
put. The women who felt this way described how, at the
time they were recruited, they would have considered
almost any option which might have prevented them from
having to undergo further invasive medical procedures
and from having to leave their baby:
‘And she said that I could try this new drug and it’s
the last resort before an epidural to take the placenta
out. So I just thought, “oh my God I don’t want an
epidural” so I tried it.’ (Hannah)
‘I’d have done anything to sort of avoid having to go
to theatre. My daughter had been taken into the
SCBU* because she was premature, so I wanted to get
to her as quickly as possible. And obviously the
quicker I delivered the placenta, the quicker would
get to my daughter.’ (Trina)
(*SCBU special care baby unit)
As a consequence of being in what they saw as a des-
perate state, most of these women described having
made their decision to take part in the trial more or less
instantly, without clarifying or seeking further informa-
tion or consulting others:
‘I just said yes straightaway. I didn’t want to mess
around, I just wanted to hold my baby really… It was
just me, snap decision, saying “yeah, right, ok”, I don’t
think I even looked at my husband.’ (Liz)
‘At time when I said yes, I didn’t need to think
about… all I knew is that I was a mum without a baby
who needed me.’ (Trina)
Some women also reflected on how, due to their
eagerness for a quick-fix solution which might prevent
them from going to theatre, they had neither been inter-
ested in, nor receptive to, learning about the possible
risks and side effects of taking GTN:
‘But yeah, you know, I didn’t really think at that point,
it was just so appealing to me that I could have a
spray and, you know, wouldn’t have to go to theatre
that I probably didn’t want to think about the risks
too much.’ (Susie)
Hence, while nearly all women were confident that
they had actively consented to take part in the trial and
that their consent had been ‘given freely’ as June put it,
the majority also questioned whether, with hindsight,
their consent had been fully informed:
‘At the time I felt I was quite informed. I felt fine
about taking part. I didn’t feel worried about it. I
know I was, it was okay… But looking back, there was
quite a lot going on. I don’t know how much I was
taking on board, so I am not sure how informed my
decision really was but, at the time, I don’t think I
cared either.’ (Diane)
In general, women did not consider their participation
to have been problematic despite questioning whether
their consent had been fully informed. This, as indicated
above, was in large part due to their positive perceptions
of the trial and the minimal demands that participation
had required. However, there was a minority who
conveyed more ambivalent views, all of whom who went
on to experience a postpartum haemorrhage or another
complication which they thought might have been due
to taking GTN:
‘I just had a massive haemorrhage then sort of straight
away… within 2 minutes of having it (trial spray), my
BP dropped and my heart rate shot up… and there
was all just suddenly doctors in the room… and I’m
thinking, “oh my God, what have I done, I’m bleeding
to death.”’ (Lynne)
‘I mean I had a really bad panic attack, it was really
intense, my heart rate was through the roof for quite
a while… And was so ill afterward, you feel like “oh
God, was that the right choice that I made”, you know
it scared me a bit that I took the choice without really
thinking about it.’ (Hannah)
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As the quotes from Lynne and Hannah also make ap-
parent, these women conveyed regret and concern about
having made a decision to take part at speed, and with-
out fully considering the risks.
Women’s views about improving the information and
consent pathway: extending information-giving into the
antenatal period
As women’s accounts made apparent, the difficulty with
giving and gaining informed consent arose from the con-
text and timing of the recruitment approach and, relat-
edly, their physical, emotional and mental states at the
time. For this reason, when asked what they thought
about the trial’s information and consent pathway, most
spontaneously suggested that their decision-making and,
hence, ability to give informed consent could potentially
have been enhanced had they been exposed to trial
information before they went into labour. Specifically,
women described how earlier exposure to this informa-
tion might have allowed them to digest and reflect upon
it at a time when they were better placed to assimilate
the details:
‘I found that, because I’d just given birth, I wasn’t in
the right mind to understand what people were saying
to me, so I think it would have been better to have
got the information before.’ (Kate)
Some also suggested that earlier provisioning of infor-
mation might have enabled them to consult others as well
as to draw upon thinking and preliminary decision-
making made at a time when they were not in a desperate
and vulnerable state. As Susie, like others, speculated, this
might have helped to prevent making a rapid decision in
an anxious and panicked state:
‘I think, I mean… “earlier” as in before the labour, kind
of during my pregnancy with midwives… because then
if I would have been approached with it, you know, me
and my husband could have maybe talked about it
beforehand and said, you know “if I did need the spray,
would I have it? You know, rather than make a quick
decision based on panic.”’ (Susie)
A minority of women, however, did question the merits
of providing trial information to all expectant mothers
given the relative rarity of RPs:
‘When you’re preparing to give birth there’s such a
small chance that you’ll, you know, have a retained
placenta, I think if there’d been more information
available I may have looked at it but I don’t think I
really would have given it much thought
beforehand.’ (Celia)
While Celia questioned the efficacy, for her, of receiving
information during the antenatal period, she was keen to
emphasise that information should be made available to
all expectant mothers so they could decide for themselves
whether or not to engage with it:
‘I am a firm believer that you should have all the
information available if you want to, you know, look
into things – I definitely think it should be down to
the mother’s choice.’ (Celia)
In keeping with Celia’s comments, most women indi-
cated that they would have welcomed this choice because,
for them, the antenatal period had been a time when they
had been ‘hungry for information’, as Alice put, in order to
be able to make informed decisions. Indeed, several
women described how they had actively sought out this
kind of information because they considered discussion of
birthing complications to be a necessary and important
part of birth planning:
‘Like I say I’d done a lot of homework into, you know,
into the third stage and everything like that, so I did
know that could go wrong, I was aware of it, and I
was aware that there are ways of dealing with it before
you have to go to theatre.’ (Susie)
‘I’m all for that the more information – knowledge
is power as far as I’m concerned. So the more that
I know the more that I feel comfortable… So I
read every – every possible scenario (both laugh)
that could have possibly happened in the birthing
room.’ (Liz)
Women’s views about improving the information and
consent pathway: extending information-giving into the
postnatal period
While most of the women recommended improving the
information and consent pathway by introducing informa-
tion about the trial during the antenatal period, some also
highlighted the benefits of revisiting this information
during the early postnatal period. This was particularly im-
portant for women who did not recall being given or who
had lost the full participant information sheet. These
women described how they had welcomed receiving copies
of trial documentation prior to their discharge from hospital
as this had allowed them to revisit and digest information
they had not been able to retain at the time of recruitment:
‘I think it was quite handy that I could take that home to
read through at some point. Because giving me anything
to sort of read, or consent to when I was in the delivery
ward was – was pretty pointless, to be honest, because I
had no idea what was going on.’ (Trina)
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For some women, the desire for more information in
the postnatal period extended beyond the provision of
formal trial information. Specifically, the minority of
women who experienced a PPH or other difficult symp-
toms (see above) highlighted the benefits of having a
debriefing session with trial and/or clinical staff, and
conveyed gratitude when they had had the chance to do
this. These women described debriefing sessions as
presenting important opportunities to revisit their expe-
riences of trial participation with staff and to learn more
about the intervention drug, in order to better under-
stand if the problems they had experienced could be
explained by having had a RP or if they might have been
due to possible exposure to GTN. As these women also
indicated, they had wanted this information as they were
seeking reassurance that, in the event of a future birth,
they would be unlikely to have a similar, traumatic
experience:
‘Maybe a little bit of after care in terms of someone
coming back and talking me through it, does that
make sense? Because obviously I’d been to theatre, I’d
had the panic attack it hadn’t worked. And after I did,
like I said, I did have a few questions, like I thought,
“could it have been the spray that caused my blood
pressure to go high?”’ (Shari)
‘Especially after having had such a bad experience
(postpartum haemorrhage), it was nice while sort of
an inpatient to have some feedback and just sit and
talk through it afterwards, you know, with the person
who approached me in the first place… Because it
worries me, if I did have another one, is it going to
happen again?’ (Lynne)
Staff views and experiences of recruitment and gaining
informed consent
Mirroring the accounts given by women, staff described
the trial as having been easy to recruit into, due to the
possible benefits to women of taking part (avoiding
theatre) and the minimal time and effort that participa-
tion required:
‘I think it kind of sells itself, I mean I can understand
why we don’t get many declining because I would find
it hard to find somebody who would say “no, I would
rather I went to theatre and have this horrible
procedure where someone puts their hand right up
inside me and pulls my placenta out.” So why would
someone go through that as opposed to sort of, you
know, doing that?’ (MW J)
While the trial was seen as an ‘easy sell’ (Dr B), staff
also reflected upon the difficulties and challenges of
having to recruit and consent women within a time-
pressured situation. Staff also noted the additional chal-
lenges arising from having to consent individuals who
might be tired, distressed and in pain and, hence, have
limited ability to concentrate:
‘It’s an interesting environment to consent patients for a
clinical trial. Because it’s quite different to a sort of, you
know, sit down clinic, have a think about something,
then write to me if you’re interested. That’s the thing,
it’s a kind of now or never scenario.’ (Dr E)
‘I think it is difficult because by definition somebody
who has just had a vaginal delivery is, therefore,
exhausted and also now has a complication. Now it
may not be immediately life-threatening, but obvi-
ously they’re aware there is a problem, so they’re anx-
ious about that.’ (Dr G)
Hence, staff, including those quoted above, reflected on
how they had felt an ethical mandate and responsibility to
convey information about the trial in clear, succinct and
accessible ways, in order to achieve understanding
amongst the women they were recruiting. To do this, staff
discussed how they had tended to simplify and give ‘the
minimum of information’ (Dr J) they thought was needed
to gain informed consent:
‘They just need to know the essentials, like the basics,
like it’s a trial; it’s a research trial… there’s a spray we
can give you, two sprays under your tongue and one is
the GTN spray and one is a fake, and we don’t know
which is which. I think just the basics, because at the
time of having a baby, there’s a lot of things going
round in a woman’s head when they’ve had a baby and
you don’t remember a lot of what’s going on.’ (MW N)
Staff also highlighted the benefits of delivering infor-
mation verbally and of using the summary rather than
the full version of the trial information sheet:
‘Because the women are under the influence of drugs,
tiredness, exhaustion, emotional, you know, it’s
important to read the information sheet to them…
Because the women, they don’t, in my opinion, have
the ability to read the information themselves and
retain everything.’ (MW H)
‘There is a leaflet that’s really detailed and I think, you
know, if they’ve had opiates and stuff was well they
won’t be in the mood for reading that, will they.
There’s a simplified version which is much more
straightforward and I think this is probably they level
you should be aiming for when someone’s just had a
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baby. I don’t mean that in a condescending way, I just
mean they are exhausted and they’ve often been up
for 2 days so giving them too much information is
unfair really.’ (DR F)
In general, staff saw their attempts as having been suc-
cessful, despite the challenging circumstances in which
recruitment had been undertaken. This was due in large
part to what they saw as their own effort and ability to
convey information clearly and succinctly, wherein: ‘I’ve
managed to do it but with difficulty’ (Dr I). In addition,
staff described having determined that informed consent
had been given by the women they had recruited based
on their observations that these individuals had generally
been able to present an understanding and rationale for
taking part:
‘…because they usually seem to sort of spell out their
rationalisation for why they went for it, you know,
“anything that might give even the smallest chance of
me going to theatre.”’ (Dr F)
‘You know from what they’ve said, the kind of general
consensus was “for the sake of it being so quick, you
know, so quick, it’s worth a shot.”’ (MW J)
Staff views about the timing of information delivery and
extending the consent pathway
Given their perception that they had been successful in
recruiting and consenting women, most staff conveyed
general satisfaction with the information and consent
pathway used. Indeed, while staff did acknowledge the
challenges of giving women information about the trial
in the period immediately following diagnosis of a RP,
they all saw this as the most appropriate time to do so:
‘Although broaching an entirely new subject about a
trial when they’ve just has a baby is not the optimum
time to give them information… I guess it’s as good a
time as any in that you know, sometimes I guess the
women are just so overwhelmed with all the
information they get in pregnancy, to speak to all
women about this trial is just a bit too much.’ (Dr B)
‘I don’t think there is an alternative, because the
alternative would be to talk to everyone who is
pregnant about this may happen and it’s really not that
relevant to the majority of the population.’ (Dr H)
Indeed, staff were reluctant to consider other
approaches, a position which did not change when
individuals were told, during their interviews, that
women had expressed a wish for earlier information-
giving. To justify their position, most staff framed
their opposition in terms of an ethic and duty of care
to all pregnant women, wherein the potential (if any)
benefits of delivering information during the antenatal
period would be outweighed by what they saw as
significant emotional costs to recipients:
‘Sometimes ignorance is bliss, you know, women, they
just have so much information given to them now
throughout their pregnancy and I’m a bit kind of like
“is it right to scare them about something that might
never happen? Because they’re already terrified about
labour.”’ (MW J)
Some of the concerns staff expressed about antenatal
information-giving also related to logistical and cost
considerations, wherein:
‘If you stop to tell everybody about this trial, but only
a couple of percent will have it (a retained placenta),
it’s gonna waste so many resources.’ (Dr J)
Other concerns related to efficacy, with some staff
suggesting that, even if information was made available
to women during the antenatal period, most individuals
would fail to engage with it, again making this an in-
appropriate use of staff effort and resources:
‘I just don’t think it would necessarily be much help…
they’re going to take in what they think is relevant
and at that time they’re not planning on having a
retained placenta, so, I just don’t think it will register
with them.’ (Dr E)
Staff did, however, highlight the potential benefits of
revisiting trial information and offering a post-trial
debriefing which, as MW N suggested, would allow
women to better understand ‘what was happening because
their head’s a bit more together’. Others, including Dr J,
noted that, in their institution, a broadly similar practice
was already made available to women who underwent
emergency procedures such as a ventouse delivery or a
caesarean section wherein: ‘We see our patients a day or
two after the procedure to explain to them what has
happened and to see if they’ve got more questions’.
Discussion
There is a growing body of work looking at consent
issues in perinatal, neonatal and other trials requiring
recruitment to be undertaken in emergency situations,
and this study contributes to this literature by reporting
the perspectives of patients (women) and staff involved
in the same trial. By exploring the recruitment and
consent encounter from these dual perspectives, we have
revealed a complex picture in which both points of
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convergence and divergence emerge. Both women and
staff agreed that giving and processing information
about a trial at the time of a diagnosis of a RP is difficult.
Furthermore, both parties saw use of simplified trial
materials (e.g. written and verbal summaries) as an
important means of imparting information to women
when their ability to concentrate might be compromised
and there is limited time in which to undertake recruit-
ment. However, while staff maintained the view that the
recruitment/consent strategy used in the Got-it pilot
was efficacious and acceptable, women, whilst noting
that their consent had been given freely at the time,
raised retrospective concerns about whether they had
actually been able to make a fully informed decision. To
understand the differences in these perspectives, the
different factors impinging on women and staff at the
time of recruitment, and what they considered the key
ethical considerations to be, need to be considered.
When undertaking recruitment at the time of an ob-
stetric emergency, staff placed emphasis on information-
giving and promoting understanding. In the main, they
saw informed consent as having been achieved, in large
part because of their perceived ability to impart informa-
tion about the trial in clear, simple and accessible ways,
and their assessments that women had understood the
information they had been given. While women also
valued clear and simple information at the time of
recruitment, they drew attention to the experiential
realities of their pre- and post-birth situations and how
these also influenced their decision-making. Like the
women in the pre-term labour trial studied by Kenyon
et al. [24], they described the context in which their
recruitment had been undertaken as having been inher-
ently pressurised. In particular, women discussed how
their eagerness to avoid going to theatre and their desire
to remain with their babies had resulted in rapid
decision-making and what they recognised, in hindsight,
to be a lack of engagement with the potential risks
involved in trial participation. Similar findings have been
reported by Snowdon et al. [35], who found that parents
involved in perinatal trials also tended to make rapid
decisions; in their case, due to fear, panic and concerns
about their baby’s safety.
To address their (retrospective) concerns about whether
fully informed consent had been given, women highlighted
the potential benefits of receiving information prior to
giving birth, a finding also reported by Ayers et al. in a
study involving parents who agreed for their babies to be
recruited into a neonatal trial [36]. These benefits included
having the opportunity to learn about the trial at a time
when they might be better placed mentally and emotionally
to consider the information provided. Women also sug-
gested that receipt of information during the antenatal
period could enable them to make preliminary decisions
when they were not in a vulnerable situation and to seek,
and engage with, the views of others, such as their
partners. The adaptations to the information and consent
pathway that women proposed, however, were not in
accordance with what staff considered feasible and appro-
priate. In this study, and by virtue of bringing the perspec-
tives of staff and women together, we identified two
potential sources of difference. These related to the nature
of the information to be given, and perceptions of the
impact of that information.
Staff saw antenatal information about the management
of RP as difficult and potentially distressing and felt that
women should be spared these details unless they
became relevant to their situation. While staff generally
accepted the value of discussing RPs and the trial after
the event, they viewed this information as irrelevant to
the majority of pregnant women, due to the relative
rarity of RPs. This view, in turn, led staff to suggest that
the effort involved in delivering information during the
antenatal period would be a misguided and ineffective
use of staff time and resources. These views contrasted
with those of women who described information
gathering during pregnancy (including information
about obstetric complications) as a key part of their
self-education and preparation for birth. Indeed, in
suggesting that information should be made available
during pregnancy, most of these women, like those
interviewed by Snowdon et al. [37] who had experi-
enced a life-threatening postpartum haemorrhage,
presented themselves as ‘information hungry’ and as
wanting to be empowered. While some agreed that
they might not have found information about RP per-
sonally salient, they did not think it was inappropriate
for pregnant women to be given this information. In-
deed, many women thought it was important for indi-
viduals to be able to decide for themselves whether
or not to engage with it.
The women in this study thus not only appeared to
be drawing upon different experiential paradigms to
those invoked by recruiting staff, they also seemed to
appeal and make recourse to different ethical dis-
courses. While women presented a rights-based ethical
justification, staff drew upon an ethical position in
which they emphasised their duty of care to all preg-
nant women. Specifically, staff weighed the potential
benefits to the minority of women who would go on to
meet trial inclusion criteria against the potential costs
to all pregnant women, who, they suggested, might find
information about RPs and the trial distressing and
burdensome. In doing so, staff also drew upon a
resource-based (ethical) discourse in which they voiced
concerns about whether the delivery of trial informa-
tion during pregnancy would be a prudent use of
(scarce) staff time and resources.
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Implications for intrapartum and peripartum research
The accounts of the women who took part in this study
offer powerful empirical endorsement for the informa-
tion and consent pathway developed by Vernon et al.
[25], and subsequently enshrined within the Royal
College of Obstetrician and Gynaecologists’ (RCOG)
guidelines [38], for use in intrapartum trials. Due to a
lack of formal clinical guidelines at the time, Vernon et
al. developed a pathway for subsequent use in a trial
which also involved recruitment of women with a RP.
To develop this pathway, they conducted a consultation
exercise with consumer groups (local and national
consumer groups, local experts in the field of consent
issues and members of an ethics committee). This con-
sultation led to the decision by Vernon et al. not only to
deliver trial information at the time of recruitment, but
also to present information during the antenatal period
(in the form of an information sheet given at a booking
appointments accompanied by tabloid style brochures
distributed in antenatal clinics and labour wards). This
method of information delivery was also backed up with
posters, publicity in the local press and links to a study
website, the intention being to raise awareness and to
give women the option of obtaining more information
should they wish to do so [25]. Such a strategy fits well
with the needs articulated by the women who took part
in our study, who were able to draw upon their actual
experiences of having been recruited into an intrapartum
trial. Indeed, the women we interviewed described both
a need and right to access trial information during
pregnancy, in order to be able to decide for themselves
whether or not to engage with it.
By also drawing upon staff perspectives, this study
highlights potential challenges to implementing an infor-
mation pathway in the antenatal period − challenges
which may also apply to other trials recruiting women with
rare obstetric complications, such as postpartum haemor-
rhage [28]. Staff resistance to delivering information during
pregnancy could be explained in part by their perceptions
that women had given properly informed consent at the
time of recruitment. Such a finding mirrors Ferguson’s
(2003) observation that staff involved in recruiting into
trials of all types are generally confident that they have
given appropriate levels of information to enable patients
to make informed decisions [39]. However, as described
above, our findings also suggest that staff resistance to
imparting information during the antenatal period could
be due to their operating within different ethical and
experiential paradigms to the women. This observation has
important implications for the design of information and
consent pathways in future trials, especially if this involves
consultation with one kind of user group (e.g. patients) but
these pathways then require implementation by another
group (e.g. health professionals). In light of our own
findings, we would recommend that careful thought be
given to the constitution of consultation groups, to ensure
the views of all parties involved in the recruitment and
consent process are taken into account. What is interesting
to note in this study is that when the findings outlined
above were presented to the implementation group
(comprising both health professionals and patient repre-
sentatives) at the end of the pilot phase, a compromise
position was reached. This involved targeting antenatal
information at women who are identified as being at
increased risk of a RP (e.g. due to having had a previous
RP [40]). In addition, the implementation group advised
cascading general information about the trial through post-
ers in antenatal clinics and community bases, and via NHS
websites and social media feeds, thereby allowing ‘informa-
tion hungry’ women the opportunity to learn about the
trial and access more detailed information should they
wish do so. See Table 5 for further details of these key
recommendations.
While the pathway recommended by Vernon et al.
[25] and subsequently by the RCOG [38], places heavy
emphasis on antenatal information delivery, the women
and staff who took part in our study also highlighted the
benefits of information-giving being extended into the
early postpartum period. In most cases, this was to allow
women to revisit information about the trial and learn
more about the details at a time when they were better
placed physically and emotionally to assimilate and
comprehend it. However, there was also a minority of
women who had experienced a postpartum hemorrhage
or another distressing complication and who expressed a
need to discuss their experiences and revisit trial infor-
mation with staff in order to make better sense of what
had happened to them. This need for a debrief has also
been expressed by women who have experienced a
postpartum haemorrhage or other severe birthing com-
plications in non-trial situations [36, 41, 42] and who
Table 5 Excerpts from Recommendations of the Implementation
Group, May 2015
It is ‘…recommended that the pathway to be used in the main trial
should draw upon the principles of the pathway developed by Vernon et
al. but be “scaled down”. It was proposed that information about the trial
should be displayed in settings where women receive their antenatal care
in the form of posters and leaflets. It was also agreed that these
documents should contain clear information about how women could
access further information should they wish to do so; for instance, by
providing contact details of trial staff and links to websites (Got-it or local
Trust websites) containing more information about the trial and about
retained placentas). The potential to use of social media such as Twitter
and Facebook was also highlighted. It was suggested that the proposed
method of information delivery would meet the needs of women who
are “information hungry” whilst not overburdening those who are not.’
It is ‘…recommended that those women who are identified as being
at increased risk of having a retained placenta (e.g. due to having had
one previously) should, when possible, be targeted during the antenatal
period and these individuals should be given a trial information sheet.’
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described feeling abandoned and left with questions if
this was not offered to them [42]. What is particularly
salient to note here is that, even if women feel satisfied
with consent procedures at the time of recruitment,
their perspectives may subsequently change. Not only
does this highlight the challenges for staff about making
assessments about women’s competency to make an
informed decision at the time of recruitment, it also
highlights the importance of following up women post
trial, especially those identified as having had negative
experiences.
A key area of agreement between women and staff lay
with the benefits of using summary and verbal versions of
trial information at the time of recruitment. The use of
this kind of approach is not currently highlighted in
RCOG guidelines for obtaining a valid consent for partici-
pation in research while in labour or in the immediate
postpartum period [38]. Arguably, however, it should be
considered for use in future trials involving recruitment of
participants experiencing physical and/or emotional
exhaustion, especially those where there is only limited
time to undertake recruitment. Not only is this a relatively
‘low cost’ option to implement, the staff who took part in
our study described how that they had found summary
information easy and appropriate to deliver.
Strengths and limitations
A key strength of this study is that it drew upon the per-
spectives and experiences of women (trial participants)
as well as those of recruiting staff and, in doing so, it has
been possible to identify discrepant and sometimes
contradictory views. In addition, and in contrast to the
study by Vernon et al. [25], these perspectives and expe-
riences were informed by involvement in a real rather
than a hypothetical trial scenario. As such, this study
offers new and potentially important insights relevant
for future trial designs. However, while women recom-
mended that trial information should be delivered
during the antenatal period, the current study did not
present an opportunity to evaluate whether, and how,
pregnant women who are not yet sensitised to the issues
around RPs might engage with, and use, this information
in practice. This is an important area for future research,
as others have also recommended [37]. While this study
also provides powerful endorsement for information to
be given at the time of recruitment in simplified verbal
and written forms, the relatively straightforward (and
hence easy to explain) nature of the Got-it trial interven-
tion needs to be taken into account. Hence, future
research could evaluate use of simplified/summary
information in more complex intrapartum trials as well
as in other trials involving recruitment in emergency
situations.
Conclusion
This qualitative study of patients’ and staff experiences
of recruitment to a peripartum trial suggests that while
gaining and giving consent to research participation in
an ‘emergency’ situation may be perceived as relatively
straightforward, the consent obtained may not be as
informed as it could be. Women’s suggestion that the
quality of informed consent could be improved by
receiving trial information during the antenatal period
was not generally supported by staff on the grounds that
this would be burdensome for both individual women
and healthcare systems. As the findings of this study
suggest, these discrepant perspectives and views may be
due to the two parties (women and staff ) drawing upon,
and making recourse to, different ethical and experien-
tial paradigms. In doing so, we have highlighted the
potential importance of including multiple perspectives
when developing information and consent pathways for
use in future (peripartum) trials.
Consent
Written informed consent was obtained from participants
for publication of their individual details and accompany-
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by the authors and is available for review by the editor-in-
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